Table of Contents Table of Contents 2 List of Tables 5 List of Figures 5 Simcere Pharmaceutical Group Snapshot 6 Simcere Pharmaceutical Group Overview 6 Key Information 6 Key Facts 6 Simcere Pharmaceutical Group - Research and Development Overview 7 Key Therapeutic Areas 7 Simcere Pharmaceutical Group - Pipeline Review 10 Pipeline Products by Stage of Development 10 Pipeline Products - Monotherapy 11 Pipeline Products - Combination Treatment Modalities 12 Pipeline Products - Partnered Products 13 Partnered Products/Combination Treatment Modalities 14 Simcere Pharmaceutical Group - Pipeline Products Glance 15 Simcere Pharmaceutical Group - Late Stage Pipeline Products 15 Phase III Products/Combination Treatment Modalities 15 Simcere Pharmaceutical Group - Clinical Stage Pipeline Products 16 Phase II Products/Combination Treatment Modalities 16 Phase I Products/Combination Treatment Modalities 17 Simcere Pharmaceutical Group - Early Stage Pipeline Products 18 IND/CTA Filed Products/Combination Treatment Modalities 18 Preclinical Products/Combination Treatment Modalities 19 Discovery Products/Combination Treatment Modalities 20 Simcere Pharmaceutical Group - Drug Profiles 21 SIM-071201 21 Product Description 21 Mechanism of Action 21 R&D Progress 21 bendamustine hydrochloride 22 Product Description 22 Mechanism of Action 22 R&D Progress 22 (amlodipine besylate + irbesartan) 23 Product Description 23 Mechanism of Action 23 R&D Progress 23 APX-003 24 Product Description 24 Mechanism of Action 24 R&D Progress 24 metatinib tromethamine 25 Product Description 25 Mechanism of Action 25 R&D Progress 25 abatacept 26 Product Description 26 Mechanism of Action 26 R&D Progress 26 BMS-817378 29 Product Description 29 Mechanism of Action 29 R&D Progress 29 OSI-930 30 Product Description 30 Mechanism of Action 30 R&D Progress 30 SIM-010603 31 Product Description 31 Mechanism of Action 31 R&D Progress 31 SIM-0710 32 Product Description 32 Mechanism of Action 32 R&D Progress 32 BMS-795311 33 Product Description 33 Mechanism of Action 33 R&D Progress 33 SCR-1693 34 Product Description 34 Mechanism of Action 34 R&D Progress 34 SIM-89 35 Product Description 35 Mechanism of Action 35 R&D Progress 35 Small Molecule to Inhibit Bruton's Tyrosine Kinase for Arthritis 36 Product Description 36 Mechanism of Action 36 R&D Progress 36 Small Molecule for Cancer 37 Product Description 37 Mechanism of Action 37 R&D Progress 37 Simcere Pharmaceutical Group - Pipeline Analysis 38 Simcere Pharmaceutical Group - Pipeline Products by Target 38 Simcere Pharmaceutical Group - Pipeline Products by Route of Administration 40 Simcere Pharmaceutical Group - Pipeline Products by Molecule Type 41 Simcere Pharmaceutical Group - Pipeline Products by Mechanism of Action 42 Simcere Pharmaceutical Group - Recent Pipeline Updates 44 Simcere Pharmaceutical Group - Dormant Projects 49 Simcere Pharmaceutical Group - Locations And Subsidiaries 50 Head Office 50 Other Locations & Subsidiaries 50 Appendix 52 Methodology 52 Coverage 52 Secondary Research 52 Primary Research 52 Expert Panel Validation 52 Contact Us 52 Disclaimer 53

List of Tables Simcere Pharmaceutical Group, Key Information 6 Simcere Pharmaceutical Group, Key Facts 6 Simcere Pharmaceutical Group - Pipeline by Indication, 2016 8 Simcere Pharmaceutical Group - Pipeline by Stage of Development, 2016 10 Simcere Pharmaceutical Group - Monotherapy Products in Pipeline, 2016 11 Simcere Pharmaceutical Group - Combination Treatment Modalities in Pipeline, 2016 12 Simcere Pharmaceutical Group - Partnered Products in Pipeline, 2016 13 Simcere Pharmaceutical Group - Partnered Products/ Combination Treatment Modalities, 2016 14 Simcere Pharmaceutical Group - Phase III, 2016 15 Simcere Pharmaceutical Group - Phase II, 2016 16 Simcere Pharmaceutical Group - Phase I, 2016 17 Simcere Pharmaceutical Group - IND/CTA Filed, 2016 18 Simcere Pharmaceutical Group - Preclinical, 2016 19 Simcere Pharmaceutical Group - Discovery, 2016 20 Simcere Pharmaceutical Group - Pipeline by Target, 2016 38 Simcere Pharmaceutical Group - Pipeline by Route of Administration, 2016 40 Simcere Pharmaceutical Group - Pipeline by Molecule Type, 2016 41 Simcere Pharmaceutical Group - Pipeline Products by Mechanism of Action, 2016 43 Simcere Pharmaceutical Group - Recent Pipeline Updates, 2016 44 Simcere Pharmaceutical Group - Dormant Developmental Projects,2016 49 Simcere Pharmaceutical Group, Subsidiaries 50 List of Figures Simcere Pharmaceutical Group - Pipeline by Top 10 Indication, 2016 8 Simcere Pharmaceutical Group - Pipeline by Stage of Development, 2016 10 Simcere Pharmaceutical Group - Monotherapy Products in Pipeline, 2016 11 Simcere Pharmaceutical Group - Partnered Products in Pipeline, 2016 13 Simcere Pharmaceutical Group - Pipeline by Top 10 Target, 2016 38 Simcere Pharmaceutical Group - Pipeline by Route of Administration, 2016 40 Simcere Pharmaceutical Group - Pipeline by Molecule Type, 2016 41 Simcere Pharmaceutical Group - Pipeline Products by Top 10 Mechanism of Action, 2016 42